HB0056 for idiopathic pulmonary fibrosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Nov 2026: Trial registered, NCT07909655

The trials

NCT07909655: A Phase 2 Study of HB0056 in Patients With Idiopathic Pulmonary Fibrosis

State
Not started
Phase
Phase 2
People
75 planned
Started
Nov 2026
Primary completion
Jan 2028
Arms
HB0056 group 1, HB0056 group 2
Results
None posted
  1. 2 Nov 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.